Article
Study on the effect of CYP2C19 genetic polymorphism and plasma concentration on clopidogrel resistance.
Pakistan journal of pharmaceutical sciences - 1 Sept 2021
Wu Hui, Chen Xinli, Ding Yongli, Deng Yanglin, Ma Ruilan, Chen Xinyuan, Li Xuesong
Abstract excerpt
At present, the mechanism for clopidogrel resistance (CR) is incompletely understood. Here, we aimed to analyze of the association of plasma concentration of clopidogrel active metabolites (CAM) and CYP2C19 genetic polymorphism with CR. We assigned 77 patients to receive CLP at a loading dose of 300mg on day 1, followed by 75mg per day from day 2 to day 6. Three peripheral venous blood samples were collected for...
Topics
Join the communities discussing this publication.
